Type to search

Economic Development Health Care News

Incyte joins S&P 500

Avatar photo

Incyte, the Delaware-based pharmaceutical research firm, has joined the S&P 500 Index.

The index includes the most-owned stocks on the New York Stock Exchange and Nasdaq, the two largest exchanges in the United States.

Incyte pushed out Spectra Energy Corp, a natural gas company in the midst of an acquisition by Enbridge.

There are now two Delaware-based companies on the S&P 500, including DuPont and now Incyte.

The company recently reported a profitable 2016, in part due to sales of its cancer-treating drug Jakafi.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2023 Delaware Business Times

Get the DBT Best Restaurants Guide

Your go-to resource for the best places for business meetings, happy hours, power lunches and more, as compiled by the Delaware Business Times editorial team.

No, thank you.
Best Restaurants Cover